Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain
Other
OA: closed
CC0
⤵ 21 in-corpus citations
AI-generated summary
This study compared maintenance therapies with tapering danazol or oral contraceptives after GnRH agonist treatment for endometriosis-associated pelvic pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Pelvic pain associated with endometriosis was treated by the long-term administration of a tapering dose of danazol or mid/low doses of oral contraceptives after the end of therapy involving a GnRH agonist (GnRH-a). Results demonstrated that each of these three therapies is a practical and efficient treatment regimen to maintain the relief of pelvic pain achieved by GnRH-a therapy, at least for a period of 12 months.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (20)
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Danazol. A synthetic steroid with diverse biologic effects via openalex
- Danazol inhibits steroidogenesis by the human ovary in vivo via openalex
- Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex
- Endometriosis: treatment strategies via openalex
- Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist via openalex
- Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial via openalex
- Treatment of deeply infiltrating endometriosis via openalex
- Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas via openalex
- W4231406039 via openalex
- W1618997004 via openalex
- W2009102624 via openalex
- W2118946732 via openalex
- W2166744769 via openalex
- W2167428807 via openalex
- W2477008945 via openalex
- W10868991 via openalex
Cited by (21)
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Medical treatment of endometriosis: is it a choice of the physician? 2020
- Hormonal contraception in women with endometriosis: a systematic review 2019
- Local estrogen formation and its regulation in endometriosis 2019
- Medical treatment of endometriosis-related pain 2018
- Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care 2017
- "Per vaginam" topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
- Estrogen-progestins and progestins for the management of endometriosis 2016
- Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis? 2015
- Endometriosis still a challenge 2014
- Systematic review of endometriosis pain assessment: how to choose a scale? 2014
- Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment 2013
- Continuous use of oral contraceptives: an overview of effects and side-effects 2012
- Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro 2012
- Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain 2011
- Brief update on endometriosis treatment 2011
- Danazol falsely increased values in estradiol immunoassays 2010
- Is there a role for acupuncture in endometriosis pain, or 'endometrialgia'? 2008
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:04:39.942088+00:00
- unpaywall
- last seen: 2026-08-15T06:29:46.044917+00:00
License: CC0
· commercial use OK